Akura Flow Organ-on-a-Chip Technology
Olivier Frey, InSphero Head of Technology and Platforms, explains how we developed a scalable and versatile organ-on-a-chip system for the study of complex diseases, such as metabolic or cardiovascular diseases, that involve a network of organs that interact with each other.
How we applied InSphero technology to create a human liver NASH model
Microphysiological systems engineered with organ-on-a-chip Technology
The Akura™ Flow MPS discovery system for organ-on-a-chip solutions provides experimental continuity between single- and multi-tissue testing applications, enabling the seamless integration and optimal utilization of standardized 3D models from a single provider. Complete systems include pre-qualified 3D InSight™ Microtissues, media, assays, and a tilting-based flow control.
3D InSight™ Islet Platform Technology
Learn how our uniform and functionally robust 3D InSight™ Human Islet models for diabetes drug discovery and pancreatic islet research can increase productivity in your lab.
Maine "207" Newsmagazine visits InSphero Inc. in Brunswick, Maine
InSphero Technology Featured in Improbable Success Television Series
What do 3D Microtissues, electric cars, and custom fitted pants have in common? When the documentary series Improbable Success focused on Switzerland, it featured interviews with biomedical technology pioneers at ETH Zurich and InSphero. Our CEO Jan Lichtenberg talks about what makes our 3D cell culture technology game-changing for drug discovery and safety testing. You'll also learn more about some other cool and innovative Swiss companies.